検索ワード: causative (英語 - マルタ語)

non response to erythropoietin therapy should prompt a search for causative factors.
in-nuqqas ta’ rispons għat-terapija bl-eritropojetin għandu iwassal għal tfitxxija ta’ fatturi kawżattivi.

failure to respond to mircera therapy should prompt for a search for causative factors.
falliment ta’ rispons għal terapija b’mircera għandu jġiegħel tfittxija għall-fatturi ta’ kawża.

non-response to therapy with aranesp should prompt a search for causative factors.
nuqqas ta’ rispons għal kura b’aranesp għandu jġiegħel li tinbeda tfittxija għal fatturi kawżattivi.

non-response to therapy with epoetin theta should prompt a search for causative factors.
nuqqas ta’ rispons għal kura b’ epoetin theta għandu jġiegħel li tinbeda tfittxija għal fatturi kawżattivi.

appropriate diagnosis should be used and therapy of causative conditions should be investigated before antimicrobial treatment is considered.
għandha tintuża dijanjożi xierqa u għandha tiġi investigata terapija ta’ kundizzjonijiet kawżattivi qabel ma tinbeda kura kontra l-mikrobi.

the schmallenberg virus is the causative agent of a previously unknown animal disease and it is probably transmitted by insects.
il-virus ta' schmallenberg huwa aġent kawżattiv ta' mard tal-annimali preċedentement mhux magħruf u probabbilment jiġi trasmess mill-insetti.

reversibility of altered renal function has been observed with supportive treatment and discontinuation of potentially causative agents, including exenatide.
Ġie osservat li t-tibdil fil-funzjoni renali huwa riversibbli b’kura ta’ sosteniment u t-twaqqif tas-sustanzi li wisq probabbli kienu l-kawża ta’ kollox, inkluż exenatide.

reversibility of altered renal function has been observed with supportive treatment and discontinuation of potentially causative medicinal products, including exenatide.
Ġie osservat li b’kura ta’ sosteniment u bit-twaqqif tal-prodotti mediċinali potenzjalment kawżattivi, li jinkludu exenatide, tista’ treġġa’ lura l-kambjament fil- funzjoni renali.

equal pay can only be achieved if action is taken at all levels, which involves all interested parties and addresses all the causative factors of the pay gap.
l-ugwaljanza fil-pagi tista’ tkun biss il-frott ta’ azzjoni fuq il-livelli kollha, li tassoċja l-partijiet interessati kollha u taġixxi fuq il-fatturi kollha li jnisslu din id-diskrepanza.

no causative impacts on public health, and in particular on the extension of the geographical distribution of tick species and tick borne diseases, will necessarily be recorded.
mhux bilfors se jkun irreġistrat xi impatt kawżattiv fuq is-saħħa tan-nies, u b'mod partikolari fuq l-estensjoni tad-distribuzzjoni ġeografika tal-ispeċi tal-qurdien u ta' mard li jinġarr mill-qurdien.

the usual duration of therapy with invanz is 3 to 14 days but may vary depending on the type and severity of infection and causative pathogen(s).
it-tul ta’ kura b’invanz is-soltu jkun bejn 3 u 14-il jum iżda jista’ jvarja skont it-tip u l-qawwa tal- infezzjoni u l-patoġenu(i) li jikkawżaha/jikkawżawha.

2 the usual duration of therapy with invanz is 3 to 14 days but may vary depending on the type and severity of infection and causative pathogen(s).
2 it- terapija ta 'invanz is- soltu ddum bejn 3 u 14- il jum imma tista' tvarja skond it- tip u s- severità ta 'l - infezzjoni u l- patoġenu/ i li jikkawżawha.

specimens for fungal culture and other relevant laboratory studies (serology, histopathology) should be obtained prior to therapy to isolate and identify causative organisms.
kampjuni għal koltura fungali u studji oħra rilevanti fil-laboratorju (seroloġija, istopatoloġija) għandhom jiġu miksuba qabel it-terapija sabiex jiġu iżolati u identifikati organiżmi kawżattivi.

the dosage of intravenous ciprofloxacin is determined by the severity and type of infection, the sensitivity of the causative organism(s) and the age, weight and renal function of the patient.
id- doża ta ’ ciprofloxacin fil- vini hija stabbilita mis- severità u t- tip ta ’ l- infezzjoni, is- sensittività ta ’ l - organiżmu( i) kawżattivi u l- età, il- piż u l- funzjoni renali tal- pazjent.

in many cases the presence of pre-existing liver enzyme abnormalities, infection with hepatitis b or hepatitis c virus, concomitant use of other potentially hepatotoxic medicines, and ongoing injecting drug use may have a causative or contributory role.
f’ ħafna każijiet, il- preżenza ta ’ anormalitajiet fl- enzimi tal- fwied, infezzjonijiet b’ virus ta ’ l- epatite b jew l- epatite Ċ, l- użu fl- istess ħin ta ’ mediċini oħra li jistgħu jikkawżaw ħsara epatika, u l- injettar tad- drogi tista ’ tkun fattur li jkun qed jikkawża jew jikkontribwixxi.

specimens for fungal culture and other relevant laboratory studies (including histopathology) should be obtained prior to therapy to isolate and identify causative organism(s).
għandhom jinkisbu kampjuni għal kultura fungali u studji rilevanti oħra tal-laboratorju (fosthom istopatoloġija) qabel it-terapija sabiex jiġu iżolati u identifikati l-organiżmi kawżattivi.